Answers are grounded in this paper and cite their sources.
Purpose: To confirm additional criteria (not including standard Tumor-Node-Metastasis (TNM) classification, prostate specific antigen (PSA) and Gleasson score) to improve stratification of hormone-naпve non-metastatic high-risk prostate cancer. Materials and methods: Detailed literature analysis with utilization of Pubmed data had been performed, and additional approaches to standard classification had been found. Conclusions: – specific criteria of high-risk prostate cancer periodically change in appropriate guidelines and clinical researches, according to different prospects in “risk” detection between different experts in oncourology and radiation oncology; – except modern classification, new data obtained concerning measurement of the tumor size can provide additional diagnostic value; – more clear visualization, exactly, multiparametric magnetic resonance imaging, can also provide appropriate information about stage and size of the tumor and, thereby, helps to identify high-risk prostate cancer; – specified definition of non-metastatic high-risk prostate cancer had been confirmed; – in high risk group patients with multiple criteria of specified condition have higher risk of cancer-specific mortality.
No takes yet. Share an insight, caveat, or question.
С. В. Головко (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: